Cargando…
Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066929/ https://www.ncbi.nlm.nih.gov/pubmed/33402651 http://dx.doi.org/10.4103/lungindia.lungindia_464_20 |
| _version_ | 1783682682796900352 |
|---|---|
| author | Udwadia, Zarir F. Sharma, Samridhi Mullerpattan, Jai B. Gajjar, Ishita Pinto, Lancelot |
| author_facet | Udwadia, Zarir F. Sharma, Samridhi Mullerpattan, Jai B. Gajjar, Ishita Pinto, Lancelot |
| author_sort | Udwadia, Zarir F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8066929 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80669292021-04-27 Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic Udwadia, Zarir F. Sharma, Samridhi Mullerpattan, Jai B. Gajjar, Ishita Pinto, Lancelot Lung India Research Letter Wolters Kluwer - Medknow 2021 2020-12-31 /pmc/articles/PMC8066929/ /pubmed/33402651 http://dx.doi.org/10.4103/lungindia.lungindia_464_20 Text en Copyright: © 2020 Indian Chest Society https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Research Letter Udwadia, Zarir F. Sharma, Samridhi Mullerpattan, Jai B. Gajjar, Ishita Pinto, Lancelot Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic |
| title | Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic |
| title_full | Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic |
| title_fullStr | Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic |
| title_full_unstemmed | Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic |
| title_short | Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic |
| title_sort | effective use of telemedicine in mumbai with a cohort of extensively drug-resistant “xdr” tuberculosis patients on bedaquiline during covid-19 pandemic |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066929/ https://www.ncbi.nlm.nih.gov/pubmed/33402651 http://dx.doi.org/10.4103/lungindia.lungindia_464_20 |
| work_keys_str_mv | AT udwadiazarirf effectiveuseoftelemedicineinmumbaiwithacohortofextensivelydrugresistantxdrtuberculosispatientsonbedaquilineduringcovid19pandemic AT sharmasamridhi effectiveuseoftelemedicineinmumbaiwithacohortofextensivelydrugresistantxdrtuberculosispatientsonbedaquilineduringcovid19pandemic AT mullerpattanjaib effectiveuseoftelemedicineinmumbaiwithacohortofextensivelydrugresistantxdrtuberculosispatientsonbedaquilineduringcovid19pandemic AT gajjarishita effectiveuseoftelemedicineinmumbaiwithacohortofextensivelydrugresistantxdrtuberculosispatientsonbedaquilineduringcovid19pandemic AT pintolancelot effectiveuseoftelemedicineinmumbaiwithacohortofextensivelydrugresistantxdrtuberculosispatientsonbedaquilineduringcovid19pandemic |